Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1987 Dec;24(6):689–697. doi: 10.1111/j.1365-2125.1987.tb03233.x

Meptazinol and pentazocine: plasma catecholamines and other effects in healthy volunteers.

T Manner 1, J Kanto 1, H Scheinin 1, M Scheinin 1
PMCID: PMC1386391  PMID: 3440093

Abstract

1. This double-blind, random-order study was designed to compare the clinical effects and the plasma catecholamine responses after i.v. administration of meptazinol at doses 0.7 and 1.4 mg kg-1, pentazocine at doses 0.3 and 0.6 mg kg-1 and saline placebo to six healthy volunteers. 2. Mean arterial pressure was not affected by either drug. Heart rate showed slight drug-related changes. Respiratory rate fell slightly with both drugs, but independently of dose. 3. The critical flicker fusion threshold-test and Maddox wing readings could both clearly differentiate active drugs from placebo. Meptazinol caused more nausea and dysphoria as expressed with visual analogue scales. Both analgesics caused short-lived feelings of euphoria. 4. After pentazocine plasma noradrenaline increased almost two-fold in 10-20 min. The effect of meptazinol was slightly smaller, whereas meptazinol caused a pronounced increase in plasma adrenaline concentrations in two of six subjects. Pentazocine had a smaller, but significant effect on plasma adrenaline. 5. We conclude that the effects of meptazinol in healthy volunteers do not differ markedly from those of pentazocine, although it may cause more nausea and dysphoria. The pronounced increase in plasma adrenaline concentrations in two of six subjects calls for caution in its use in patients with cardiac diseases.

Full text

PDF
689

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bill D. J., Hartley J. E., Stephens R. J., Thompson A. M. The antinociceptive activity of meptazinol depends on both opiate and cholinergic mechanisms. Br J Pharmacol. 1983 May;79(1):191–199. doi: 10.1111/j.1476-5381.1983.tb10512.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chestnutt W. N., Dundee J. W. The influence of cyclizine and perphenazine on the emetic effect of meptazinol. Eur J Anaesthesiol. 1986 Jan;3(1):27–32. [PubMed] [Google Scholar]
  3. Goldstein D. S., Feuerstein G., Izzo J. L., Jr, Kopin I. J., Keiser H. R. Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci. 1981 Feb 2;28(5):467–475. doi: 10.1016/0024-3205(81)90139-9. [DOI] [PubMed] [Google Scholar]
  4. Green D. Current concepts concerning the mode of action of meptazinol as an analgesic. Postgrad Med J. 1983;59 (Suppl 1):9–12. [PubMed] [Google Scholar]
  5. Hannington-Kiff J. G. Measurement of recovery from outpatient general anaesthesia with a simple ocular test. Br Med J. 1970 Jul 18;3(5715):132–135. doi: 10.1136/bmj.3.5715.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hannington-Kiff J. G. Residual post-operative paralysis. Proc R Soc Med. 1970 Jan;63(1):73–76. [PMC free article] [PubMed] [Google Scholar]
  7. Hindmarch I. Psychomotor function and psychoactive drugs. Br J Clin Pharmacol. 1980 Sep;10(3):189–209. doi: 10.1111/j.1365-2125.1980.tb01745.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hjemdahl P., Akerstedt T., Pollare T., Gillberg M. Influence of beta-adrenoceptor blockade by metoprolol and propranolol on plasma concentrations and effects of noradrenaline and adrenaline during i.v. infusion. Acta Physiol Scand Suppl. 1983;515:45–53. [PubMed] [Google Scholar]
  9. Holmes B., Ward A. Meptazinol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs. 1985 Oct;30(4):285–312. doi: 10.2165/00003495-198530040-00001. [DOI] [PubMed] [Google Scholar]
  10. Jones J. G. The respiratory effects of meptazinol. Postgrad Med J. 1983;59 (Suppl 1):72–77. [PubMed] [Google Scholar]
  11. Jordan C., Lehane J. R., Robson P. J., Jones J. G. A comparison of the respiratory effects of meptazinol, pentazocine and morphine. Br J Anaesth. 1979 Jun;51(6):497–502. doi: 10.1093/bja/51.6.497. [DOI] [PubMed] [Google Scholar]
  12. Kaiko R. F., Wallenstein S. L., Rogers A. G., Canel A., Jacobs B., Houde R. W. Intramuscular meptazinol and morphine in postoperative pain. Clin Pharmacol Ther. 1985 May;37(5):589–596. doi: 10.1038/clpt.1985.92. [DOI] [PubMed] [Google Scholar]
  13. Manner T., Kanto J., Salonen M. Simple devices in differentiating the effects of buprenorphine and fentanyl in healthy volunteers. Eur J Clin Pharmacol. 1987;31(6):673–676. doi: 10.1007/BF00541294. [DOI] [PubMed] [Google Scholar]
  14. Manner T., Kanto J., Salonen M. Use of simple tests to determine the residual effects of the analgesic component of balanced anaesthesia. Br J Anaesth. 1987 Aug;59(8):978–982. doi: 10.1093/bja/59.8.978. [DOI] [PubMed] [Google Scholar]
  15. Mattila M. J., Aranko K., Mattila M. E., Strömberg C. Objective and subjective assessment of hangover during subacute administration of temazepam and nitrazepam to healthy subjects. Eur J Clin Pharmacol. 1984;26(3):375–380. doi: 10.1007/BF00548770. [DOI] [PubMed] [Google Scholar]
  16. Paymaster N. J. Analgesia after operation. A controlled comparison of meptazinol, pentazocine and pethidine. Br J Anaesth. 1977 Nov;49(11):1139–1146. doi: 10.1093/bja/49.11.1139. [DOI] [PubMed] [Google Scholar]
  17. Revill S. I., Robinson J. O., Rosen M., Hogg M. I. The reliability of a linear analogue for evaluating pain. Anaesthesia. 1976 Nov;31(9):1191–1198. doi: 10.1111/j.1365-2044.1976.tb11971.x. [DOI] [PubMed] [Google Scholar]
  18. Richens A., Allen E., Jones D., Griffiths A., Marshall R. A comparison of intramuscular meptazinol (100 mg) and papaveretum (20 mg) on human performance studies in healthy male volunteers. Postgrad Med J. 1983;59 (Suppl 1):19–24. [PubMed] [Google Scholar]
  19. Robson P. J. Clinical review of parenteral meptazinol. Postgrad Med J. 1983;59 (Suppl 1):85–92. [PubMed] [Google Scholar]
  20. SIMONSON E., BROZEK J. Flicker fusion frequency; background and applications. Physiol Rev. 1952 Jul;32(3):349–378. doi: 10.1152/physrev.1952.32.3.349. [DOI] [PubMed] [Google Scholar]
  21. Smith J. M., Misiak H. Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects-a review. Psychopharmacologia. 1976 May 28;47(2):175–182. doi: 10.1007/BF00735818. [DOI] [PubMed] [Google Scholar]
  22. Spiegel K., Pasternak G. W. Meptazinol: a novel Mu-1 selective opioid analgesic. J Pharmacol Exp Ther. 1984 Feb;228(2):414–419. [PubMed] [Google Scholar]
  23. Tammisto T., Jättelä A., Nikki P., Takki S. Effect of pentazocine and pethidine on plasma catecholamine levels. Ann Clin Res. 1971 Feb;3(1):22–29. [PubMed] [Google Scholar]
  24. Wilkinson D. J., O'Connor S. A., Dickson G. R., Drake H. F. Meptazinol--a cause of respiratory depression in general anaesthesia. Br J Anaesth. 1985 Nov;57(11):1077–1084. doi: 10.1093/bja/57.11.1077. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES